Zhirong Zhang Selected Research

Liposomes (Liposome)

1/2022	A neutrophil-mediated carrier regulates tumor stemness by inhibiting autophagy to prevent postoperative triple-negative breast cancer recurrence and metastasis.
1/2022	Live Macrophage-Delivered Doxorubicin-Loaded Liposomes Effectively Treat Triple-Negative Breast Cancer.
10/2021	Mild hyperthermia promotes immune checkpoint blockade-based immunotherapy against metastatic pancreatic cancer using size-adjustable nanoparticles.
10/2021	A "dual-guide" bioinspired drug delivery strategy of a macrophage-based carrier against postoperative triple-negative breast cancer recurrence.
10/2020	Improved melanoma suppression with target-delivered TRAIL and Paclitaxel by a multifunctional nanocarrier.
10/2020	Targeting cancer-associated fibroblasts by dual-responsive lipid-albumin nanoparticles to enhance drug perfusion for pancreatic tumor therapy.
2/2020	A new tandem peptide modified liposomal doxorubicin for tumor "ecological therapy".
1/2020	Targeting self-assembly peptide for inhibiting breast tumor progression and metastasis.
11/2019	Tumor-Targeted Chemoimmunotherapy with Immune-Checkpoint Blockade for Enhanced Anti-Melanoma Efficacy.
11/2019	Synergistic cytotoxicity and co-autophagy inhibition in pancreatic tumor cells and cancer-associated fibroblasts by dual functional peptide-modified liposomes.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhirong Zhang Research Topics

Disease

153	Neoplasms (Cancer) 11/2022 - 09/2003
37	Neoplasm Metastasis (Metastasis) 01/2022 - 02/2014
27	Melanoma (Melanoma, Malignant) 11/2021 - 01/2012
25	Breast Neoplasms (Breast Cancer) 01/2022 - 12/2014
17	Inflammation (Inflammations) 01/2022 - 02/2009
11	Glioma (Gliomas) 10/2020 - 11/2011
8	Pancreatic Neoplasms (Pancreatic Cancer) 10/2021 - 05/2019
8	Carcinoma (Carcinomatosis) 07/2018 - 09/2009
8	Necrosis 05/2016 - 02/2012
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 07/2014
6	Rheumatoid Arthritis 01/2021 - 01/2016
5	Hypoxia (Hypoxemia) 02/2022 - 01/2016
5	Triple Negative Breast Neoplasms 01/2022 - 03/2020
5	Infections 01/2022 - 02/2010
5	Lung Neoplasms (Lung Cancer) 07/2019 - 11/2014
5	Brain Neoplasms (Brain Tumor) 01/2018 - 04/2014
4	Arthritis (Polyarthritis) 12/2021 - 01/2016
3	Adenocarcinoma 01/2022 - 11/2019
3	Hyperthermia 10/2021 - 10/2020
3	Experimental Arthritis 10/2021 - 01/2017
3	Fibrosis (Cirrhosis) 01/2021 - 11/2019
3	Parkinson Disease (Parkinson's Disease) 10/2018 - 09/2014
3	Reperfusion Injury 03/2018 - 10/2014
3	Esophageal Squamous Cell Carcinoma 01/2018 - 01/2016
3	Retinal Neovascularization 12/2016 - 01/2016
3	Alzheimer Disease (Alzheimer's Disease) 09/2016 - 05/2009
3	Hemolysis 03/2015 - 02/2014

Drug/Important Bio-Agent (IBA)

52	Pharmaceutical PreparationsIBA 01/2022 - 12/2004
47	Liposomes (Liposome)IBA 01/2022 - 10/2010
35	Peptides (Polypeptides)IBA 10/2020 - 02/2012
27	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 05/2013
26	MicellesIBA 01/2022 - 11/2011
18	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 12/2009
16	Therapeutic UsesIBA 01/2022 - 01/2013
15	LigandsIBA 01/2022 - 09/2013
14	IntegrinsIBA 10/2021 - 07/2014
13	Proteins (Proteins, Gene)FDA Link 04/2022 - 02/2012
9	CytokinesIBA 10/2021 - 10/2014
9	LipidsIBA 08/2021 - 01/2012
9	Hyaluronic Acid (Hyaluronan)IBA 04/2020 - 01/2015
8	Biological ProductsIBA 01/2022 - 09/2015
8	AcidsIBA 10/2021 - 02/2015
8	Small Interfering RNA (siRNA)IBA 10/2020 - 02/2014
8	Cell-Penetrating PeptidesIBA 11/2018 - 10/2010
7	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 10/2021 - 01/2017
6	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2022 - 01/2016
6	Messenger RNA (mRNA)IBA 01/2021 - 01/2016
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2020 - 08/2013
6	AntigensIBA 07/2019 - 02/2015
6	PolymersIBA 10/2017 - 11/2008
6	hydroxypropyl methacrylateIBA 01/2017 - 09/2003
5	AlbuminsIBA 04/2022 - 10/2017
5	celastrolIBA 01/2022 - 10/2017
5	P-SelectinIBA 01/2022 - 01/2017
5	liposomal doxorubicin (Doxil)FDA Link 01/2021 - 12/2014
5	CholesterolIBA 11/2018 - 11/2011
5	Antineoplastic Agents (Antineoplastics)IBA 01/2017 - 01/2014
4	VaccinesIBA 11/2022 - 10/2014
4	Cysteine (L-Cysteine)FDA Link 04/2022 - 10/2010
4	pirarubicinIBA 04/2022 - 11/2015
4	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2022 - 10/2017
4	Biocompatible Materials (Biomaterials)IBA 11/2021 - 01/2016
4	MicroRNAs (MicroRNA)IBA 01/2021 - 11/2014
4	EnzymesIBA 01/2020 - 04/2013
4	Ethylene Glycol (Monoethylene Glycol)IBA 05/2019 - 10/2010
4	Phospholipids (Phosphatides)FDA LinkGeneric 04/2019 - 06/2014
4	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 02/2015 - 11/2008
4	Lipid NanoparticlesIBA 01/2015 - 06/2014
4	Fluorouracil (Carac)FDA LinkGeneric 07/2014 - 06/2005
4	Mitoxantrone (Novantrone)FDA LinkGeneric 12/2009 - 12/2004
3	Human Serum Albumin FDA LinkGeneric 04/2022 - 11/2015
3	VNP 20009 (VNP20009)IBA 01/2022 - 01/2018
3	ChemokinesIBA 10/2021 - 10/2014
3	Immune Checkpoint InhibitorsIBA 10/2021 - 07/2019
3	N-Acetylneuraminic Acid (Sialic Acid)IBA 08/2021 - 11/2018
3	PolyethyleneimineIBA 10/2020 - 10/2014
3	CollagenIBA 02/2020 - 10/2016
3	Insulin (Novolin)FDA Link 04/2019 - 02/2006
3	Folic Acid (Vitamin M)FDA LinkGeneric 11/2018 - 09/2009
3	Dopamine (Intropin)FDA LinkGeneric 10/2018 - 09/2014
3	Dexamethasone (Maxidex)FDA LinkGeneric 04/2018 - 01/2016
3	Glucosamine (Dona)IBA 03/2018 - 10/2014
3	ungeremine (AT 1840)IBA 01/2018 - 01/2013
3	Retinaldehyde (Retinal)IBA 12/2016 - 01/2016
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2016 - 01/2016
3	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 11/2016 - 12/2014
3	methacrylamideIBA 01/2016 - 09/2003
2	Scavenger Receptors (Scavenger Receptor)IBA 04/2022 - 11/2020

Therapy/Procedure

67	Therapeutics 04/2022 - 11/2011
34	Drug Therapy (Chemotherapy) 12/2021 - 07/2011
17	Immunotherapy 01/2022 - 02/2015
9	Lasers (Laser) 01/2022 - 02/2010
6	Photothermal Therapy 01/2022 - 01/2018
4	Lymph Node Excision (Lymph Node Dissection) 01/2021 - 07/2014
4	Injections 06/2019 - 01/2012
4	Intravenous Injections 11/2018 - 01/2013
4	Intravenous Administration 06/2014 - 12/2009
3	Radiotherapy 10/2021 - 07/2014
3	Aftercare (After-Treatment) 01/2018 - 12/2016
3	Combination Drug Therapy (Combination Chemotherapy) 08/2017 - 11/2015